Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

The Benefit of Adjuvant Radiation in Surgically-Treated T1-2 N1 Oropharyngeal Squamous Cell Carcinoma.

Monroe MM, Buchmann LO, Hunt JP, Hitchcock YJ, Lloyd S, Hashibe M.

Laryngoscope Investig Otolaryngol. 2017 Feb 2;2(2):57-62. doi: 10.1002/lio2.64. eCollection 2017 Apr.

2.

Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma.

Faraji F, Eisele DW, Fakhry C.

Laryngoscope Investig Otolaryngol. 2017 Jan 17;2(1):10-18. doi: 10.1002/lio2.37. eCollection 2017 Feb. Review.

3.

HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer.

Jung YS, Najy AJ, Huang W, Sethi S, Snyder M, Sakr W, Dyson G, Hüttemann M, Lee I, Ali-Fehmi R, Franceschi S, Struijk L, Kim HE, Kato I, Kim HC.

Oncotarget. 2017 May 16;8(31):51530-51541. doi: 10.18632/oncotarget.17887. eCollection 2017 Aug 1.

4.

Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.

Lindsay CD, Kostiuk MA, Harris J, O'Connell DA, Seikaly H, Biron VL.

Clin Epigenetics. 2017 Sep 6;9:95. doi: 10.1186/s13148-017-0390-y. eCollection 2017.

5.

Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review.

Hutcheson KA, Yuk M, Hubbard R, Gunn GB, Fuller CD, Lai SY, Lin H, Garden AS, Rosenthal DI, Hanna EY, Kies MS, Lewin JS.

Head Neck. 2017 Aug;39(8):1516-1523. doi: 10.1002/hed.24789. Epub 2017 Apr 28.

PMID:
28452175
6.

Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC.

Swick AD, Prabakaran PJ, Miller MC, Javaid AM, Fisher MM, Sampene E, Ong IM, Hu R, Iida M, Nickel KP, Bruce JY, Wheeler DL, Kimple RJ.

Mol Cancer Ther. 2017 Jul;16(7):1257-1268. doi: 10.1158/1535-7163.MCT-17-0115. Epub 2017 Apr 26.

PMID:
28446642
7.

Discussing HPV with oropharyngeal cancer patients: A cross-sectional survey of attitudes in health professionals.

Dodd RH, Forster AS, Waller J, Marlow LAV.

Oral Oncol. 2017 May;68:67-73. doi: 10.1016/j.oraloncology.2017.03.014. Epub 2017 Apr 1.

8.

A Pilot Study into the Association between Oral Health Status and Human Papillomavirus-16 Infection.

Sun CX, Bennett N, Tran P, Tang KD, Lim Y, Frazer I, Samaranayake L, Punyadeera C.

Diagnostics (Basel). 2017 Mar 1;7(1). pii: E11. doi: 10.3390/diagnostics7010011.

9.

Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.

Walline HM, Goudsmit CM, McHugh JB, Tang AL, Owen JH, Teh BT, McKean E, Glover TW, Graham MP, Prince ME, Chepeha DB, Chinn SB, Ferris RL, Gollin SM, Hoffmann TK, Bier H, Brakenhoff R, Bradford CR, Carey TE; University of Michigan Head and Neck Specialized Program of Research Excellence (SPORE) Program.

Head Neck. 2017 May;39(5):840-852. doi: 10.1002/hed.24729. Epub 2017 Feb 25.

PMID:
28236344
10.

LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma.

Ma X, Sheng S, Wu J, Jiang Y, Gao X, Cen X, Wu J, Wang S, Tang Y, Tang Y, Liang X.

Oncotarget. 2017 Jun 27;8(26):42061-42075. doi: 10.18632/oncotarget.14939.

11.

Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers.

Verma G, Vishnoi K, Tyagi A, Jadli M, Singh T, Goel A, Sharma A, Agarwal K, Prasad SC, Pandey D, Sharma S, Mehrotra R, Singh SM, Bharti AC.

Cancer Med. 2017 Mar;6(3):591-604. doi: 10.1002/cam4.983. Epub 2017 Feb 3.

12.

Identification of HPV Types and Mycobacterium Tuberculosis Complex in Historical Long-Term Preserved Formalin Fixed Tissues in Different Human Organs.

Hühns M, Erbersdobler A, Obliers A, Röpenack P.

PLoS One. 2017 Jan 23;12(1):e0170353. doi: 10.1371/journal.pone.0170353. eCollection 2017.

13.

Evaluation of the Correlation between CD44, Tumor Prognosis and the 5-Year Survival Rate in Patients with Oral Tongue SCC.

Kaboodkhani R, Karimi E, Khorsandi Ashtiani MT, Kowkabi S, Firouzifar MR, Yazdani F, Yazdani N.

Iran J Otorhinolaryngol. 2016 Nov;28(89):407-411.

14.

The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.

Zumsteg ZS, Lok BH, Ho AS, Drill E, Zhang Z, Riaz N, Shiao SL, Ma J, McBride SM, Tsai CJ, Baxi SS, Sherman EJ, Lee NY.

Cancer. 2017 Apr 15;123(8):1345-1353. doi: 10.1002/cncr.30495. Epub 2016 Dec 16.

PMID:
27984656
15.

The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.

Skillington SA, Kallogjeri D, Lewis JS Jr, Piccirillo JF.

JAMA Otolaryngol Head Neck Surg. 2017 Mar 1;143(3):253-259. doi: 10.1001/jamaoto.2016.3353.

PMID:
27918781
16.

Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.

Wang Z, Xia RH, Ye DX, Li J.

PLoS One. 2016 Oct 17;11(10):e0164491. doi: 10.1371/journal.pone.0164491. eCollection 2016.

17.

Awareness and knowledge of Human Papillomavirus (HPV), HPV-related cancers, and HPV vaccines in an uninsured adult clinic population.

Radecki Breitkopf C, Finney Rutten LJ, Findley V, Jacobson DJ, Wilson PM, Albertie M, Jacobson RM, Colón-Otero G.

Cancer Med. 2016 Nov;5(11):3346-3352. doi: 10.1002/cam4.933. Epub 2016 Oct 17.

18.

A multicenter study of oral malignant tumors from Thailand.

Dhanuthai K, Rojanawatsirivej S, Subarnbhesaj A, Thosaporn W, Kintarak S.

J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):462-466.

19.

Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.

Beadle BM, Liao KP, Giordano SH, Garden AS, Hutcheson KA, Lai SY, Guadagnolo BA.

Cancer. 2017 Jan 1;123(2):283-293. doi: 10.1002/cncr.30350. Epub 2016 Sep 23.

PMID:
27662641
20.

Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.

Keysar SB, Le PN, Miller B, Jackson BC, Eagles JR, Nieto C, Kim J, Tang B, Glogowska MJ, Morton JJ, Padilla-Just N, Gomez K, Warnock E, Reisinger J, Arcaroli JJ, Messersmith WA, Wakefield LM, Gao D, Tan AC, Serracino H, Vasiliou V, Roop DR, Wang XJ, Jimeno A.

J Natl Cancer Inst. 2016 Sep 15;109(1). pii: djw189. doi: 10.1093/jnci/djw189. Print 2017 Jan.

PMID:
27634934

Supplemental Content

Support Center